| abstract |
The present invention relates to a film comprising a monovalent cationic alginate or a mixture of alginate comprising at least one monovalent cationic alginate, and triptan or a pharmaceutically acceptable salt thereof. The invention further relates to a method for producing such a film, and to the use of such a film in the treatment of diseases in human patients, in particular migraine, cluster headache or trigeminal neuralgia with or without aura. [Selection diagram] None |